Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Taipurui Biotechnology is a medical technology company headquartered in Taizhou, China, specializing in the development and manufacture of in vitro diagnostic (IVD) solutions. The company focuses on molecular diagnostics, particularly PCR-based kits for infectious disease screening and women's health. Its flagship products include high-throughput Human Papillomavirus (HPV) DNA typing kits and automated nucleic acid extraction systems. Taipurui serves clinical laboratories and healthcare providers by providing integrated diagnostic workflows that combine reagents with automated instrumentation. The company is situated within the China Medical City (CMC) hub, leveraging regional infrastructure for biotech innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Taipu Rui Biotechnology.